Subscribe to Newsletter
Discovery & Development Drug Discovery

T Cells, Sea Shells and Cancer Cures

| 5 min read

Adrian Baez-Ortega shares on pioneering the genome sequencing of transmissible cancers in cockles – and what this research means for humans.

Business & Regulation Standards & Regulation

Health Canada Unhappy with Florida’s Drug Importation Plans

| Stephanie Vine | 3 min read

As the Sunshine State looks to import medicines to lower costs for Floridians, what of ongoing shortages for Canadians?

Business & Regulation Standards & Regulation

Another Year of Innovation

| Stephanie Vine

A video tour of the top FDA approvals from 2023

Manufacture Bioprocessing - Upstream & Downstream

Propelling the Promise of mRNA

| Rob Coker | 4 min read

With mRNA technology scooping the 2023 Nobel Prize for Medicine, demand is growing. Can CDMOs keep up?

Discovery & Development Drug Delivery

Taking Vaccines Beyond Borders

| Jamie Irvine | 3 min read

Can yeast-based vaccines help overcome global vaccine inequity challenges?

Discovery & Development Drug Discovery

Pharma’s Portal to the Lab of the Future

| Becky Upton | 4 min read

Labs of the future will use VR, AR, AI and more. But we must overcome the barriers of implementation, including cultural resistance.

Manufacture Advanced Medicine

In Support of the Supply Chain

| Fiona Withey | 7 min read

From automation to integration, there is huge room for improvement in supply chain management systems for cell and gene therapies

Discovery & Development Drug Discovery

Release the Beast

| Pandora Pound | 5 min read

The FDA Modernization Act opens the door for more innovative alternatives to animal testing for drug discovery and development

Discovery & Development Drug Discovery

Addressing Epilepsy

| Stefanie Dedeurwaerdere | 4 min read

The challenges of complex disorders require collaboration, embracing technological developments, and acknowledging the gaps in access to medicine

Discovery & Development Drug Delivery

At First Sight

| Jamie Irvine | 13 min read

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register